SCF(SKP2) polyubiquitinates RUNX2

Stable Identifier
R-HSA-8939706
Type
Reaction
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

The SCF(SKP2) E3 ubiquitin ligase complex polyubiquitinates RUNX2 on unknown lysine residues, targeting it for proteasome-mediated degradation. SKP2-triggered RUNX2 degradation negatively regulates osteogenesis by inhibiting differentiation of osteoblasts (Thacker et al. 2016). This process is inhibited by glucose uptake in osteoblasts (Wei et al. 2015).

Literature References
PubMed ID Title Journal Year
26091038 Glucose Uptake and Runx2 Synergize to Orchestrate Osteoblast Differentiation and Bone Formation

Pessin, JE, Wei, J, Lezaki, T, Hinoi, E, Shimazu, J, Kajimura, D, Karsenty, G, Zong, H, Maurizi, A, Makinistoglu, MP, Takarada, T

Cell 2015
26778333 Skp2 inhibits osteogenesis by promoting ubiquitin-proteasome degradation of Runx2

Khan, MP, Kumar, Y, Trivedi, AK, Kanaujiya, JK, Kapoor, I, Sanyal, S, Thacker, G, Chattopadhyay, N, Lochab, S, Ahmed, S, Shukla, N

Biochim. Biophys. Acta 2016
Participants
Participates
Catalyst Activity

ubiquitin protein ligase activity of RUNX2:SCF(SKP2) [nucleoplasm]

Orthologous Events
Authored
Reviewed
Created
Cite Us!